[Fructose-1,6-diphosphate administration during extracorporeal circulation. I. Reduction of post-perfusion hemolysis].
D004912:Erythrocytes / Q000502:physiology; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005635:Fructosediphosphates / Q000008:administration & dosage*; D006461:Hemolysis / Q000187:drug effects*; D006598:Hexosediphosphates / Q000008:administration & dosage*; D006801:Humans; D011897:Random Allocation; D013314:Stress, Mechanical
D005635:Fructosediphosphates; D006598:Hexosediphosphates; C029063:fructose-1,6-diphosphate
Impiego del fruttoso-1,6-difosfato durante circolazione extracorporea. I. Riduzione dell'emolisi post-perfusionale.